C16 Ceramide

Research use only, not for human use.

C16 Ceramide (Palmitoyl Ceramide) is a naturally occurring small molecule that activates p53 by directly and selectively binding to it.

C16-Ceramide is a natural small molecule activating p53 through the direct and selective binding.

C16-Ceramide interacts with p53 within its core domain. p53 forms complex with natural C16-Ceramide in the cell.C16-Ceramide (2.5-50 μM; 0-48 h) strongly decreased HCT116 cell viability in a time- and concentration-dependent manner.C16-Ceramide (12 μM; 48 h) induces apoptosis through Btf (Bcl-2-associated transcription factor) in HCT116 cells.C16-ceramide (12 μM; 0-6 h) and Btf expression up-regulate p53 and BAX expression. C16-ceramide down-regulates Mdm2 expression via Btf.Cell Viability Assay Cell Line:HCT116 cells Concentration:2.5, 5, 10, 12, 20, 50 μM Incubation Time:0-48 h Result:Strongly decreased cell viability in a time- and concentration-dependent manner.Western Blot Analysis Cell Line:HCT116 cells Concentration:12 μM Incubation Time:1, 3 and 6 h Result:Increased PARP cleavage, decreased pro-caspase 3. Decreased the levels of stratifin and stathmin, increased the expression of prohibitin and Btf. RNAi-mediated Btf depletion also partially inhibited BAX expression after the treatment. Significantly decreased luciferase activity and Mdm2 protein expression levels.

——

——

Apoptosis

p53

p53

——

——

24696-26-2

537.9

C34H67NO3

>98% (HPLC)

In Vitro:?Ethanol : 20 mg/mL (37.18 mM; warming and heat to 60°C)DMF : 20 mg/mL (37.18 mM; Ultrasonic (<60°C))

CCCCCCCCCCCCCCCC(=O)NC(CO)C(O)C=CCCCCCCCCCCCCC

——

(-20℃)

With Ice Pack

≥ 2 years